Antimicrobial peptides (APs) impose a threat to the survival of pathogens, and it is reasonable to postulate that bacteria have developed strategies to counteract them. Polymyxins are becoming the last resort to treat infections caused by multidrug-resistant Gram-negative bacteria and, similar to APs, they interact with the anionic lipopolysaccharide. Given that polymyxins and APs share the initial target, it is possible that bacterial defense mechanisms against polymyxins will be also effective against host APs. We sought to determine whether exposure to polymyxin will increase Klebsiella pneumoniae resistance to host APs. Indeed, exposure of K. pneumoniae to polymyxin induces cross-resistance not only to polymyxin itself but also to APs present in the airways. Polymyxin treatment upregulates the expression of the capsule polysaccharide operon and the loci required to modify the lipid A with aminoarabinose and palmitate with a concomitant increase in capsule and lipid A species containing such modifications. Moreover, these surface changes contribute to APs resistance and also to polymyxin-induced cross-resistance to APs. Bacterial loads of lipid A mutants in trachea and lungs of intranasally infected mice were lower than those of wild-type strain. PhoPQ, PmrAB, and the Rcs system govern polymyxin-induced transcriptional changes, and there is a cross talk between PhoPQ and the Rcs system. Our findings support the notion that Klebsiella activates a defense program against APs that is controlled by three signaling systems. Therapeutic strategies directed to prevent the activation of this program could be a new approach worth exploring to facilitate the clearance of the pathogen from the airways.
environments. The sensors of these two-component systems respond to particular cues by modulating the phosphorylation status of their cognate regulators which are often transcription factors. As a result, genes necessary for growth and survival are upregulated, whereas genes deleterious for infectivity might be downregulated. It can be speculated that bacteria may utilize two-component systems to transduce AP-mediated signals, leading to the activation of bacterial defense mechanisms. Supporting this idea, the Salmonella PhoPQ two-component system regulates genes necessary for intracellular survival and cellular invasion, and it is required for resistance to a subset of APs (6, 20, 21, 25, 26) .
Polymyxin B (PxB) and PxE (colistin) are two antibiotics originally derived from Bacillus polymyxa and made available for clinical use in the late 1950s and early 1960s. Polymyxins are pentacationic amphipathic lipopeptide antibiotics characterized by a heptapeptide ring and a fatty acid tail (63) . Polymyxins are active against Gram-negative bacteria and, similar to APs, they do interact with the anionic LPS. Soon after their introduction, the clinical use was limited due to perceived toxic side effects and the emergence of new antimicrobials (17, 35) . However, the occurrence of multidrug-resistant Gram-negative bacteria has prompted researchers to reconsider polymyxin therapies (24, 63) . Nevertheless, the pharmacokinetics and pharmacodynamics of polymyxins are poorly understood, making it possible that bacteria are exposed to sublethal concentrations during treatment. Consequently, the possibility exists that bacteria may activate defense mechanisms against polymyxins. Furthermore, given that polymyxins and APs share the initial target, it is possible that PxB countermeasures will also be effective against host APs, thus contributing to bacterial resistance and survival in host tissues.
To study this hypothesis, we used the Gram-negative human pathogen K. pneumoniae. The frequent isolation of K. pneumoniae multidrug-resistant strains makes polymyxins a therapeutic option (24) . There is a paucity of information on the mechanisms of resistance of this pathogen against polymyxins and APs. By mass spectrometry and genetic methods, we demonstrate that PxB indeed induces the expression of loci conferring resistance against PxB but also against host APs. We demonstrate that these loci play an important role in K. pneumoniae virulence. Finally, we show that at least three signaling transduction systems govern PxB-induced changes.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plasmids used in the present study are listed in Table 1 . Strains were grown in LuriaBertani (LB) medium at 37°C. When appropriate, antibiotics were added to the growth medium at the following concentrations: rifampin at 25 g/ml, ampicillin at 100 g/ml for K. pneumoniae and 50 g/ml for Escherichia coli; kanamycin (Km) at 100 g/ml; and chloramphenicol (Cm) at 12.5 g/ml.
K. pneumoniae 52145 mutant construction. Primers for mutant construction (Table 2) were designed based on the available genome sequence of K. pneumoniae subsp. pneumoniae MGH78578 (GenBank accession no. CP000647.1). DNA fragments for phoPQ, rcsB, and pagP were PCR amplified, gel purified, and cloned into pGEM-T Easy (Promega) to obtain pGEMTphoPQ, pGEMTrcsB, and pGEMTpagP, respectively. These plasmids were amplified by inverse PCR using the method described by Byrappa et al. (9) to delete internal coding regions of phoQ, rcsB, and pagP. A Km resistance cassette, obtained as a 1.4-kb PstI blunt-ended fragment from pUC-4K (Pharmacia), was cloned into the plasmids obtained by inverse PCR to generate pGEMT⌬phoPQGB and pGEMT⌬pagPGB. ⌬phoPQ::GB, ⌬rcsB, and ⌬pagP::GB alleles were obtained by PvuII digestion of pGEMT⌬phoPQGB, pGEMT⌬rcsB, and pGEMT⌬pagPGB, respectively, gel-purified and cloned into SmaI-digested pMAKSACB. pMAKSACB is a suicide vector that carries a rep101ts origin of replication, an oriT sequence for conjugational transfer, and a Cm resistance marker (19) . It also carries the sacB gene that mediates sucrose sensitivity as a positive selection for the excision of the vector after double crossing-over (19) . pMAKSAC⌬phoPQGB, pMAKSAC⌬rcsB, and pMAKSAC⌬pagPGB were electroporated into E. coli S17-1pir, from which the plasmids were mobilized into K. pneumoniae 52145. Transconjugants were selected after growth on LB plates supplemented with Cm at 30°C. Bacteria from 10 individual colonies were pooled in 500 l of phosphate-buffered saline (PBS), serially diluted in PBS, and spread onto LB plates with Cm that were incubated at 42°C in order to select merodiploids in which the suicide vector was integrated into the chromosome by homologues recombination. A total of 5 to 10 merodiploids were serially diluted in PBS, and dilutions were spread in LB plates without NaCl containing 10% sucrose and were incubated at 30°C. The recombinants that survived 10% sucrose were checked for their antibiotic resistance, and the appropriate replacement of the wild-type alleles by the mutant ones was confirmed by PCR (data not shown). Recombinants selected were named 52145-⌬phoQGB; 52145-⌬rcsB, and 52145-⌬pagPGB. To confirm that pagP mutation has no polar effects, the expression of the downstream gene, cpsE, was analyzed by real-time quantitative PCR (RT-qPCR). Briefly, 200 ng of cDNA, obtained by retrotranscription of 2 g of total RNA using a commercial RT 2 first-strand kit (Superarray Bioscience Corp.), were used as a template in a 25-l reaction mixture containing 1ϫ SYBR green RT 2 qPCR master mix (Superarray Bioscience Corp.) and primer mix. rpoD was amplified as control. RT-qPCR analyses were performed as previously described (48) . The expression of cpsE by 52145-⌬pagPGB was similar to that by the wild-type strain (data not shown).
DNA fragments for pmrAB and pmrF were PCR amplified, gel purified, and cloned into pGEM-T Easy (Promega) to obtain pGEMTpmrAB and pGEMT pmrF, respectively. These plasmids were amplified by inverse PCR to delete the internal coding regions of pmrAB and pmrF, respectively. A Km resistance cassette, obtained as a 1.5-kb PCR fragment from pKD4 (14) , was cloned into the plasmids obtained by inverse PCR to generate pGEMT⌬pmrABKm and pGEMT⌬pmrFKm. ⌬pmrAB::Km and ⌬pmrF::Km alleles were obtained by PvuII digestion of pGEMT⌬pmrABKm, and pGEMT⌬pmrFKm, respectively, and cloned into SmaI-digested pKOV (42) . Recombinants in which the wild-type allele was replaced by the mutant one were selected as described previously and named 52145-⌬pmrABKm, and 52145-⌬pmrFKm. The kanamycin cassette was excised by Flp-mediated recombination using plasmid pFLP2 (37) , and the generated mutants were named 52145-⌬pmrAB and 52145-⌬pmrF. RT-qPCR analysis revealed that the expression of pmrI, the pmrF downstream gene, was not significantly different between pmrF mutant and the wild-type strain (data not shown).
To obtain a pmrD mutant, two sets of primers (Table 2 ) were used to obtain two different pmrD fragments, PmrDUP and PmrDDown. These fragments were annealed at their overlapping region and amplified by PCR as a single fragment, which was cloned into pGEM-T Easy to obtain pGEMT⌬pmrD. A Km cassette was PCR amplified from pKD4 and cloned into pGEM-T Easy to give pGEMT FRTKM. The cassette was obtained as a BamHI fragment, which was cloned into BamHI-digested pGEMT⌬pmrD to generate pGEMT⌬pmrDKm. The ⌬pmrD::Km allele was gel purified after PvuII digestion of pGEMT⌬pmrDKm and cloned into SmaI-digested pKOV (42) . Recombinants in which the wild-type allele was replaced by the mutant one were selected as described previously and named 52145-⌬pmrDKm. The kanamycin cassette was excised by Flp-mediated recombination using plasmid pFLP2 (37) , and the generated mutant was named 52145-⌬pmrD.
The 52145-⌬phoQGB-⌬pmrAB and 52145-⌬phoQGB-⌬rcsB double mutants were obtained mobilizing the pMAKSAC⌬phoPQGB plasmid into 52145-⌬pmrAB and 52145-⌬rcsB, respectively. The replacement of the wild-type alleles by the mutant ones was done as described above and confirmed by PCR (data not shown).
Construction of reporter fusions. DNA fragments containing the promoter regions of the cps, pmrH, pagP, mgtA, pmrD, phoP, ugd, rcsD, and rcsC genes were amplified by PCR using Vent polymerase, EcoRI digested, gel purified, and cloned into EcoRI-SmaI-digested pGPL01 suicide vector (29) . This vector contains a promoterless firefly luciferase gene (lucFF) and an R6K origin of replication. Plasmids in which lucFF was under the control of the Klebsiella promoters were identified by restriction digestion analysis and named pGPLKpnPcps, pGPLKpnPmrH, pGPLKpnPagP, pGPLKpnMgtA, pGPLKpnPmrD, pGPLKpnPhoP, pGPLKpnPugd, pGPLKpnPrcsD, and pGPLKpnPrcsC, respectively. Plasmids were electroporated into the different Klebsiella strains used in the present study. Strains in which the suicide vector was integrated into the genome by homologous recombination were selected. This was confirmed by Southern blot (data not shown).
Luciferase activity. The reporter strains were grown on an orbital incubator shaker (180 rpm) until late log phase and, when required, PxB (1 g/ml) was added, and the culture was incubated for 1 h more. At the end of the incubation the optical density at 540 nm (OD 540 ) was recorded. A 100-l aliquot of the bacterial suspension was mixed with 100 l of luciferase assay reagent (1 mM D-luciferin [Synchem] in 100 mM citrate buffer [pH 5]). The luminescence was immediately measured with a LB9507 Luminometer (Berthold) and expressed as relative light units/OD 540 . All measurements were carried out in quintuplicate on at least three separate occasions.
Antimicrobial peptide susceptibility assay. Bacteria were grown at 37°C in 5 ml of LB medium and harvested (2,500 ϫ g, 20 min, 24°C) in the exponential growth phase (OD 600 ϭ 0.6). When required, PxB (1 g/ml) was added, and the culture incubated for 1 h more. Bacteria were washed once with PBS, and a suspension containing ϳ10 6 CFU/ml was prepared in 10 mM PBS (pH 6.5), 1% tryptone soy broth (Oxoid), and 100 mM NaCl. Aliquots (5 l) of this suspension were mixed in 1.5-ml microcentrifuge tubes with various concentrations of AP. In all cases, the final volume was 30 l. After 1 h of incubation at 37°C, the contents of the tubes were plated on LB agar. Colony counts were determined, and the results were expressed as percentages of the colony count of bacteria not exposed to antibacterial agents. All experiments were performed with duplicate samples on at least four independent occasions. The 50% inhibitory concentration (IC 50 ) of AP was defined as the concentration producing a 50% reduction in the colony counts compared to bacteria not exposed to the antibacterial agent. According to guidelines of the National Institutes of Health Chemical Genomics Center (www.ncgc.nih.gov), the IC 50 of a given AP was determined from dose-response curve data fit using a standard four-parameter logistic nonlinear regression analysis. Dose-response experiments were performed on four independent occasions. The results are reported as means Ϯ standard deviations.
Isolation and analysis of lipid A. Lipid A's were extracted using an ammonium hydroxide/isobutyric acid method and subjected to negative-ion matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry analysis (16, 53) . Briefly, lyophilized bacteria (10 mg) were resuspended in 400 l of isobutyric acid-1 M ammonium hydroxide (5:3 [vol/vol] ) and incubated in a screw-cap test tube at 100°C for 2 h, with occasional vortexing. Samples were cooled in ice water and centrifuged (2,000 ϫ g for 15 min). The supernatant was MG1655 grown in LB medium at 37°C. Interpretation of the negative-ion spectra is based on earlier studies showing that ions with masses higher than 1,000 gave signals proportional to the corresponding lipid A species present in the preparation (3, 41, 52, 58) . Important theoretical masses for the interpretation of peaks found in the present study were as follows: C 14:OH , 226; C 12 , 182, C 14 , 210; aminoarabinose (Ara4N), 131; and C 16 , 239. Capsule polysaccharide (CPS) purification and quantification. Cell-associated CPSs from K. pneumoniae strains, grown in 5 ml of LB, were obtained using the hot phenol-water method exactly as previously described (10) . CPS was quantified by determining the concentration of uronic acid in the samples, using a modified carbazole assay (7), exactly as described by Rahn and Whitfield (57) .
Intranasal infection model. Six-to seven-week-old virus-free female C57BL/ 6JOlaHsd mice (Harlan) were anesthetized by intraperitoneal injection with a mixture containing ketamine (50 mg/kg) and xylazine (5 mg/kg). Bacteria were grown at 37°C in 5 ml of LB medium, harvested (2,500 ϫ g, 20 min, 24°C) in the exponential growth phase, resuspended in PBS, and adjusted to 10 6 CFU/ml. Portions (20 l) of the bacterial suspension were inoculated intranasally in four 5-l aliquots. To facilitate consistent inoculations, mice were held vertically Statistical analysis. Statistical analyses were performed using one-way analysis of variance with Bonferroni contrasts or the two-tailed t test or when, the requirements were not met, by the Mann-Whitney U test. A P value of Ͻ0.05 was considered statistically significant. The analyses were performed using Prism4 for PC (GraphPad Software).
RESULTS
Exposure of K. pneumoniae to PxB increases the resistance to antimicrobial peptides. We sought to determine whether exposure to PxB increases the resistance of Kp52145, the wildtype strain, to PxB. The results shown in Fig. 1A demonstrate that 1 h of treatment with PxB (1 g/ml) resulted in a markedly increased resistance to killing by this agent. To test whether exposure to PxB also induces cross-resistance to other APs, killing assays were performed with human ␤-defensin 1 (hBD1) and hBD2, HNP-1, and magainin II. hBD1 is constitutively expressed in the airways (46) . hBD2 is produced by airway epithelial cells upon induction by cytokines or by the presence of pathogens (33, 34, 46, 59) , and its levels increase severalfold in the lungs during pneumonia (36) . HNP-1 is produced by neutrophils and released to the medium after degranulation (22) . Magainin II is an AP produced by frogs, and it is widely used as a model AP (45) . Bacteria treated with PxB were also more resistant against hBD1, hBD2, HNP-1, and magainin II than untreated bacteria (Fig. 1) . In summary, these observations demonstrate that K. pneumoniae resistance to APs can be induced by exposure to PxB.
Exposure of K. pneumoniae to PxB increases capsule expression and LPS modifications. Recently, we have shown that K. pneumoniae CPS acts as a protective shield against APs (10), whereas released CPS traps APs, thereby blocking their bactericidal activity (43) . Moreover, there is a correlation between the amount of CPS and the resistance to PxB (10) . Therefore, the observed PxB-induced resistance could be mediated by an increase in CPS expression. Indeed, exposure of Kp52145 to PxB (1 g/ml) upregulated the transcription of the cps operon ( Fig. 2A) with a concomitant increased in the amount of cellbound CPS (64.4 Ϯ 3 g/10 4 CFU versus 113 Ϯ 5 g/10 4 CFU, respectively; P Ͻ 0.05 [two-tailed t test]). To test whether PxB-induced resistance was solely due to the increased expression of CPS, we analyzed the effect of PxB on 52145-⌬wca K2 a CPS mutant. Figure 2 demonstrates that exposure of 52145-⌬wca K2 to PxB also induced cross-resistance to PxB (Fig. 2B) , hBD1 (Fig. 2C), hBD2 (Fig. 2D) , HNP-1 (Fig. 2E) , and magainin II (Fig. 2F) . To compare the PxB-induced levels of resistance against the different APs between Kp52145 and 52145-⌬wca K2 , we determined the IC 50 s of APs for these strains pretreated with PxB. The IC 50 s of PxB, hBD1, hBD2, HNP-1, and magainin II for PxB-treated Kp52145 were 4.5 Ϯ 0.8, 19 Ϯ 1.1, 10.2 Ϯ 0.6, 48 Ϯ 2.1, and 56 g/ml, respectively, values which were significantly higher than those of PxB, hBD1, hBD2, HNP-1, and magainin II for PxB-treated 52145-⌬wca K2 (2.6 Ϯ 0.7, 12.5 Ϯ 0.9, 7.0 Ϯ 0.5, 14 Ϯ 3.1, and 36.8 g/ml, respectively; P Ͻ 0.05 for each comparison versus Kp52145 values [two-tailed t test]). Taken together, these observations suggest that PxB-induced resistance is in part CPSdependent, but there are CPS-independent mechanisms operating as well.
Bacteria can modify the lipid A part of LPS by adding aminoarabinose, phosphoethanolamine, or palmitate to reduce the interaction of the peptides with the lipid A (28, 30, 31, 40, 51) . We speculated that the CPS-independent PxB-induced mechanism(s) of resistance could involve changes in the lipid A structure. To explore this notion, we determined the structure of lipid A extracted from Kp52145 after exposure to PxB by MALDI-TOF mass spectrometry (Fig. 3) . Lipid A from Kp52145 grown without PxB contained predominantly hexaacylated species (m/z 1,824) corresponding to two glucosamines, two phosphates, four 3-OH-C 14 , and two C 14 . Other peaks (m/z 1,840) may represent a hexa-acylated lipid A containing two glucosamines, two phosphates, four 3-OH-C 14 , one C 14 , and one C 14:OH (hydroxymyristate). Minor species (m/z 1,797) may correspond to a hexa-acylated lipid A containing four 3-OH-C 14 , one C 12 , and one C 14. Other minor species detected were consistent with the addition of aminoarabinose (m/z 1,955) to the hexa-acylated form (m/z 1,824) or palmitate to the hexa-acylated species (m/z 1,797 and 1,824), hence producing hepta-acylated lipid A's (m/z 2,036 and 2,063) (Fig. 3A) . PxB induced an increase in the relative abundance of the minor lipid A species containing aminoarabinose (m/z 1,955) and palmitate (m/z 2,036 and 2,063) (Fig. 3B) . Collectively, these results might indicate that exposure to PxB increases K. pneumoniae lipid A modifications containing aminoarabinose and palmitate. 
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Perusal of the literature shows that the products of ugd and pmrHFIJKLM (arnBCADTEF) (hereafter referred to as the pmrF operon) loci are required for the synthesis and addition of aminoarabinose to lipid A. Ugd converts UDP-D-glucose into UDP-D-glucuronic acid, which is next modified by pmrF operon-encoded enzymes to generate aminoarabinose (56) . The gene coding for the acyltransferase pagP is required for the addition of palmitate to lipid A (31). To verify that these loci were indeed implicated in PxB-triggered lipid A modifications with aminoarabinose and palmitate, we analyzed the lipid A structure from 52145-⌬pmrF, 52145-⌬pagPGB, and 52145-⌬pmrF-⌬pagPGB mutants. The three strains expressed the same amounts of cell-bound CPS (65.6 Ϯ 8 g/10 4 CFU, 69.5 Ϯ 7 g/10 4 CFU, and 61.6 Ϯ 9 g/10 4 CFU, respectively) as Kp52145 (64.4 Ϯ 3 g/10 4 CFU; P Ͼ 0.05 for each comparison versus Kp52145 value [two-tailed t test]). The results shown in Fig. 4 demonstrate that the pmrF mutant grown with PxB lacked lipid A species containing aminoarabinose, whereas the pagP mutant grown with PxB did not contain species containing palmitate. 52145-⌬pmrF-⌬pagPGB lacked species containing aminoarabinose and palmitate. It should be noted that lipid A species containing hydroxymyristate (C 14:OH ; m/z 1,840) and palmitate (m/z 2,036 and 2,063) were not affected in 52145-⌬pmrF, whereas lipid A species containing hydroxymiristate and aminoarabinose (m/z 1,955) were not affected in 52145-⌬pagPGB.
These findings led us to study whether PxB upregulates the expression of ugd, pmrF operon, and pagP. To monitor transcription of these loci quantitatively, three transcriptional fusions were constructed in which a promoterless lucFF was under the control of the loci promoter regions. The fusions were introduced into Kp52145, and the luciferase activity was determined. PxB upregulated the expression of ugd::lucFF, pmrH::lucFF, and pagP::lucFF transcriptional fusions (Fig. 5) , thereby giving experimental support to our hypothesis.
Aminoarabinose and palmitate lipid A substitutions contribute to K. pneumoniae antimicrobial peptide resistance. We sought to determine the contribution of aminoarabinose and palmitate lipid A substitutions to resistance against PxB and magainin II. 52145-⌬pmrF was more susceptible to PxB than the wild-type strain but as susceptible as 52145-⌬wca K2 , whereas 52145-⌬wca K2 -⌬pmrF was the most susceptible strain (Fig. 6A) . 52145-⌬pmrF was as resistant as Kp52145 to magainin II, indicating that the lipid A decoration with aminoarabinose is not implicated in the resistance to this AP (Fig.  6A) . On the other hand, lipid A substitution with palmitate does not play any role in PxB resistance but does play a role in resistance to other peptides, such as magainin II (31) . As expected, 52145-⌬pagPGB was as resistant as Kp52145 to PxB (data not shown). However, 52145-⌬pagPGB was more susceptible than Kp52145 to magainin II (Fig. 6B) . 52145-⌬wca K2 -⌬pagPGB, lacking CPS and palmitate, was the most susceptible strain to magainin II (Fig. 6B) .
We assessed the contribution of aminoarabinose or palmitate lipid A modifications to PxB-induced resistance to PxB and magainin II. The IC 50 of PxB for PxB-treated Kp52145 was 4.5 Ϯ 0.8 g/ml, which is significantly higher than those for Collectively, these data support the notion that CPS and the lipid A substitutions with aminoarabinose and palmitate contribute to AP resistance in K. pneumoniae and also to PxBinduced cross-resistance to APs.
Virulence of K. pneumoniae lipid A mutans. To determine the ability of 52145-⌬pmrF, 52145-⌬pagPGB, and 52145-⌬pmrF-⌬pagPGB to cause pneumonia, C57BL/6JOlaHsd mice were infected intranasally, and bacterial loads at 24 and 96 h postinfection in the trachea and lung homogenates were determined (Fig. 7) . At 24 h postinfection, all strains colonized trachea and lungs, although the bacterial loads of mutant strains were lower than those of the wild type in both organs (Fig. 7A) . A similar picture was observed at 96 h postinfection (Fig. 7B) . The bacterial loads of mutants were not significantly different in either trachea or lungs at 24 and 96 h postinfection (Fig. 7) . 
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Signaling networks controlling PxB induced capsule and LPS lipid A modifications. Having established that PxB upregulated the expressions of cps, pmrF, ugd, and pagP, we sought to identify the regulatory architecture that mediates PxB-triggered upregulation of them. The Rcs (Regulator of capsule synthesis) phosphorelay system consists of three proteins; RcsC, RcsD (also called YojN), and RcsB, the latter being a cytoplasmic response regulator (44) . The Rcs system fine-tunes the expression of CPS in several Enterobacteriaceae, and it mediates AP resistance (15, 65) . PhoPQ and PmrAB two-component systems mediate AP resistance by activating loci, leading to lipid A remodeling, including pagP, pmrF operon, and ugd (25, 27) . In Salmonella enterica, the expression of pmrH and ugd is controlled by PmrAB, whose activity can be modulated by the PhoPQ-dependent PmrD connector protein at the posttranscriptional level (25, 27, 39) .
To define the contribution of these systems to PxB-induced upregulation of cps, pmrF, ugd, and pagP, we investigated the transcription of these loci in isogenic mutants with or without PxB treatment. Basal levels of the cps transcriptional fusion were lower in 52145-⌬rcsB and 52145-⌬pmrAB than in Kp52145 (Fig. 8A) . PxB induced the fusion only in the 52145-⌬rcsB, 52145-⌬pmrD and 52145-⌬pmrAB backgrounds and to the same levels obtained in Kp52145 (Fig. 8A) . PxB treatment upregulated the expression of the pmrH transcriptional fusion in 52145-⌬rcsB, 52145-⌬phoQ, 52145-⌬pmrAB, and 52145-⌬pmrD backgrounds, although the levels obtained in the 52145-⌬rcsB background were significantly higher than those (Fig. 8B) . A similar picture was observed for ugd::lucFF (Fig. 8C) . PxB did not upregulate the expression of pmrH and ugd fusions in the mutant lacking both phoQ and pmrAB ( Fig. 8B and C) . PxB upregulated the pagP::lucFF fusion only in Kp52145, 52145-⌬rcsB, 52145-⌬pmrAB, and 52145-⌬pmrD (Fig. 8D) , and the levels found in the 52145-⌬rcsB background were the highest obtained (Fig. 8D) .
To further sustain the role of PhoPQ in PxB-induced transcriptional effects, we analyzed whether PxB upregulates the expression of mgtA, whose expression is PhoPQ dependent (60) . As expected, PxB upregulated the expression of mgtA in Kp52145, 52145-⌬pmrAB, and 52145-⌬pmrD backgrounds to similar levels but not in 52145-⌬phoQ mutant (Fig. 8E) . Interestingly, mgtA expression in the 52145-⌬rcsB background was significantly higher than those in the other strains (Fig. 8E ). Finally, we tested whether PxB induced the expression of the pmrD connector in a PhoPQ-dependent manner. Indeed, this was the case (Fig. 8F) . Furthermore, PxB-induced levels of the pmrD fusion were similar in Kp52145 and 52145-⌬pmrAB on September 12, 2017 by guest http://iai.asm.org/ backgrounds, and the highest levels were observed again in the 52145-⌬rcsB mutant background (Fig. 8F) . In summary, these data indicate that PhoPQ is necessary for PxB-triggered induction of cps and pagP. PxB induction of pmrH and ugd was only abolished in the double-mutant phoQpmrAB, suggesting that both two-component systems can promote PxB-induced lipid A modification with aminoarabinose. Confirming this hypothesis, lipid A species containing aminoarabinose were only absent in the PxB-treated phoQ-pmrAB double mutant background (see Fig. S1 in the supplemental material).
Cross talk between Rcs and PhoPQ systems. Considering that pmrH, ugd, pagP, mgtA, and pmrD loci were overexpressed in the rcsB mutant background and that PhoPQ regulates their expression, we hypothesized that the expression of phoPQ could be upregulated in the rcsB mutant background. To explore this, the expression of phoP::lucFF was measured in different genetic backgrounds upon PxB treatment. The data shown in Fig. 9 indicate that phoP was overexpressed in 52145-⌬rcsB but downregulated in 52145-⌬phoQ (Fig. 9A) . PxB upregulated phoP transcription in Kp52145 and 52145-⌬rcsB backgrounds, with the highest levels being those found in the latter. This was dependent on PhoPQ because phoP transcription was not upregulated in a double mutant lacking rcsB and phoQ (Fig. 9A) . phoP expression was not affected in 52145-⌬pmrAB background (data not shown). Altogether, these data gave experimental support to the hypothesis that phoPQ is upregulated in the rcsB mutant background. To further sustain this notion, we sought to determine whether the expressions of pagP, mgtA, and pmrD are upregulated in the 52145-⌬rcsB-phoQ mutant. As expected, this was not the case (Fig. 9B to D) . Furthermore, PxB did not upregulate these loci in the 52145-⌬rcsB-phoQ background (Fig. 9B to D) , which is in good agreement with the findings showing that PhoPQ is necessary for their PxB-mediated induction. Finally, we sought to determine whether the upregulation of pmrH and ugd obtained in the rcsB mutant background was also dependent on PhoPQ. Indeed, the expression of pmrH and ugd was not upregulated in 52145-⌬rcsB-phoQ ( Fig. 9E and F) . In sharp contrast to pagP, mgtA, and pmrD, the expressions of pmrH and ugd were still induced by PxB in 52145-⌬rcsB-phoQ ( Fig. 9E and F) , which is consistent with our data showing that PmrAB also promotes PxBinduced upregulation of these loci (Fig. 7) .
We explored whether the expression of the Rcs system is affected in phoQ, pmrAB, phoQ-pmrAB, and pmrD mutant backgrounds. To monitor transcription of the Rcs system, we analyzed the expression of rcsD::lucFF and rcsC::lucFF transcriptional fusions. Basal levels of the rcsD fusion were lower in 52145-⌬phoQ and 52145-⌬phoQ-pmrAB than those obtained in Kp52145, 52145-⌬pmrAB, and 52145-⌬pmrD, which were not significantly different between them (Fig. 9G) . A similar picture was observed for the rcsC fusion (Fig. 9H) . rcsD transcription was downregulated in 52145-⌬rcsB (Fig. 9G) , whereas the expression of the rcsC fusion was abolished in 52145-⌬rcsB (Fig. 9H) . The former result is in good agreement with the autoregulation of the Rcs system, whereas the latter one is consistent with the fact that RcsB is essential for rcsC expression (44) . PxB treatment upregulated the expression of rcsD; however, PxB-induced rcsD expression was lower in 52145-⌬phoQ and 52145-⌬phoQ-pmrAB than in Kp52145, 52145-⌬pmrAB, and 52145-⌬pmrD (Fig. 9G) . PxB did not induce the fusion in 52145-⌬rcsB (Fig. 9G) . Similar results were observed when the expression of rcsC was analyzed upon PxB treatment (Fig. 9H) .
On the whole, these data support the notion that there is cross talk between the Rcs and PhoPQ systems. Whereas the Rcs system downregulates phoP, the PhoPQ system promotes the expression of rcsD and rcsC.
Finally, we tested the susceptibility to PxB of the three transduction systems. The results shown in Fig. 10 demonstrate that the most susceptible strain was 52145-⌬rcsB-phoQ (IC 50 ϭ 0.42 Ϯ 0.2 g/ml), followed by 52145-⌬phoQ-pmrAB (IC 50 ϭ 0.77 Ϯ 0.1 g/ml), the two single mutants 52145-⌬phoQ (IC 50 ϭ 1.17 Ϯ 0.2 g/ml) and 52145-⌬pmrAB (IC 50 ϭ 1.25 Ϯ 0.3 g/ml), and Kp52145 (IC 50 ϭ 2.1 Ϯ 0.3 g/ml). 52145-⌬rcsB (IC 50 ϭ 2.3 Ϯ 0.4 g/ml) was as susceptible as the wild type.
DISCUSSION
In the present study, we provide new insights into how a bacterial pathogen activates countermeasures to fight against APs. Our findings revealed that brief treatment of a virulent isolate of K. pneumoniae with PxB induces cross-resistance to APs found in humans, as well as to magainin II and PxB. Mechanistically, PxB triggers changes in K. pneumoniae surface that contribute to AP resistance and PxB-induced crossresistance. Finally, we demonstrate that lipid A modifications are important for K. pneumoniae survival in the airways.
Our data showed that PxB-induced cross-resistance to APs not structurally related (32, 62) , thereby indicating that PxBtriggered resistance is not specific for the compound used. Since APs share the initial electrostatic interaction with the anionic bacterial surface, we hypothesized that PxB treatment should affect the bacterial surface. Indeed, PxB treatment upregulated the expression of the cps operon and the loci required to modify the lipid A with aminoarabinose and palmitate with a concomitant increase in CPS and lipid A species containing such modifications. Moreover, these surface changes were linked to AP resistance. Previous data (10, 43) , further confirmed here, had shown that K. pneumoniae CPS mediates resistance to several APs. In the present study, we also demonstrate that lipid A modifications with aminoarabinose and palmitate are required for AP resistance. It should be noted that these Klebsiella countermeasures are not redundant since double mutants lacking CPS and lipid A modifications were more susceptible to APs than the single mutants. Although here we have just considered surface changes, we do not rule out that other bacterial systems could also be affected. In fact, we put forward the notion that upon challenge with PxB, or other APs such as defensins, K. pneumoniae may alter global gene expression. It is tempting to speculate that these bacterial global changes could be a "molecular pattern" devoted to counteract the innate immune system, including the activation of inflammatory responses and the microbicidal action of professional phagocytes (macrophages and neutrophils). Studies are ongoing to confirm this hypothesis.
Lipid A analysis revealed the presence of a species (m/z 1,840) consistent with the presence of hydroxymyristate (C 14:OH ). This species has been previously reported for K. pneu-moniae (11) and S. enterica serovar Typhimurium (23) . For the latter, the dioxygenase responsible for 2-hydroxylation, named LpxO, has been identified (23) . This enzyme generates 2-hydroxymyristate by hydroxylation of the myristate fatty acid transferred to lipid A by the acyltransferase MsbB/LpxM (23) . In silico analysis of the available K. pneumoniae genomes revealed that this pathogen may encode an orthologue of LpxO. Studies are ongoing to characterize K. pneumoniae LpxO and whether this lipid A modification plays any role in the resistance to APs. A remaining question is to explain at the molecular level the species (m/z 1,744) found only in strains treated with PxB. This species is consistent with elimination of one (12, 38, 61, 64) . Future studies will attempt to identify this putative K. pneumoniae lipid A phosphatase. Our analysis of the regulatory architecture governing PxBinduced changes revealed that the two-component system PhoPQ is necessary for the PxB induction of cps, pagP, mgtA, and pmrD. These findings further support the notion that brief treatment with APs activates the PhoPQ regulon, as first reported by Bader et al. in S. enterica serovar Typhimurium (4). However, the fact that PxB treatment increased the expressions of rcsC, rcsD, pmrH, and ugd in the phoQ mutant suggests that PhoPQ is not the only sensor/regulator governing PxBinduced AP resistance in K. pneumoniae. Indeed, our results demonstrate that PmrAB also transduces the PxB-dependent regulatory signal. Thus, only in the phoQ pmrAB double-mutant background did PxB not upregulate the expressions of pmrH and ugd, a finding consistent with the presence of PhoP and PmrA boxes in the promoter regions of both loci (47) . This is in contrast to what happens in Salmonella since, under the conditions used here, the PxB-dependent upregulation of pmrH and ugd is dependent on PmrAB via the activation of PhoPQ and PmrD (27, 28, 30, 39) . Interestingly, PxB treatment activated the Rcs system, as detected by the upregulation of the rcsC and rcsD transcriptional fusions. Despite the fact that the levels of both fusions were 20% lower in phoQ and phoQ pmrAB mutants than in Kp52145, PxB still increased the expression of rcsC and rcsD, suggesting that, at least, an additional regulatory system may govern PxB-induced changes. Our data suggest that indeed the Rcs system could be this other system since PxB no longer induces the rcsD fusion in the rcsB mutant. Furthermore, our observation that the most susceptible strain to PxB was the rcsB phoQ double mutant suggests that there are Rcs-dependent responses implicated in the resistance to APs. This does not contradict the fact that the rcsB mutant was as susceptible as the wild-type strain to PxB because we have demonstrated that PhoPQ-dependent responses were upregulated in this genetic background. Therefore, it is tempting to conclude that these putative Rcs-dependent AP countermeasures play a role only in the absence of the PhoPQ-dependent ones.
An important issue is to understand how these signaling systems sense APs to activate a transcriptional program. It has been proposed that Salmonella PhoQ binds APs in an acidic patch of the periplasmic domain, which leads to PhoQ autophosphorylation and the subsequent phosphotransfer to PhoP (5, 54, 55) . K. pneumoniae PhoQ also contains this acidic patch, and therefore a similar mechanism of PhoQ activation by APs might be expected. At present, we can only speculate on how the PmrAB and Rcs systems are activated by APs. To date, no structural study has analyzed in-depth PmrB proteins, although the activation of Salmonella PmrB has been linked to the binding of cations to a periplasmic domain (27) . Alternatively, activation of the membrane sensors could result from outer membrane perturbations and not involve a direct interaction with APs. Considering that all APs disorganize the outer membrane (62) , it would be logical that Gram-negative pathogens have evolved means to detect membrane integrity through the use of membrane-located proteins. In support of this model, it has been shown recently that different APs activate the Rcs system through increased accessibility of the RcsF protein to the inner membrane or periplasm (18) . It is possible that APs may activate each signaling system in a different way, which will give Gram-negative bacteria the opportunity to integrate different signals to promote phenotypic changes leading to AP resistance. This could also explain why the differences between the wild type and the single mutants are not dramatic, since the response is mediated by a collective effort of at least three signaling systems.
We demonstrate here for the first time, using a pneumonia mouse model, that lipid A modifications are important for bacterial survival in the lung. Previously, we demonstrated that CPS mediates resistance against APs (10, 43) , and it is known that CPS is an important Klebsiella virulence factor (13) . Collectively, it can be postulated that there is a correlation between resistance to APs and the ability to cause pneumonia. There are several APs in the airway liquid, including lysozyme, lactoferrin, ␣-defensins, ␤-defensins, and cathelicidins (1). Therefore, the mutants' susceptibility to APs could explain the decreased bacterial loads of these strains in airways. However, the in vivo scenario is complex, and the final outcome of pneumonia is a combination of the action of antimicrobial factors (among others complement and APs) and several types of cells, including alveolar macrophages, epithelial cells, and neutrophils. It should be noted that cytokines and chemokines released by epithelial cells do upregulate the expression of APs and also increase the bactericidal activity of professional phagocytes. Studies are ongoing to determine whether lipid A modifications play any role in the interplay of K. pneumoniae with airway cells.
Polymyxins are considered the "last hope" for treating infections caused by multidrug-resistant Gram-negative bacteria including K. pneumoniae. Our results demonstrate that exposure to PxB induces cross-resistance not only to PxB itself but FIG. 10 . Role of K. pneumoniae Rcs, PhoPQ, and PmrAB systems in bacterial susceptibility to PxB. Wild-type (Kp52145), 52145-⌬rcsB (rcsB), 52145-⌬phoQGB (phoQ), 52145-⌬pmrAB (pmrAB), 52145-⌬phoQGB-⌬pmrAB (phoQ-pmrAB), and 52145-⌬rcsB-⌬phoQGB (rcsB-phoQ) strains were exposed to different concentrations of PxB. Each point represents the mean and standard deviation of eight samples from four independently grown batches of bacteria.
also to APs present in the airways. Interestingly, the results from our laboratory indicate that K. pneumoniae prevents the expression of APs by airway cells (48) . Collectively, these findings are consistent with a scenario in which the setting of pneumonia by K. pneumoniae will be facilitated by, on the one hand, preventing the expression of APs and, on the other hand, activating countermeasures against them. In turn, we put forward the idea that therapeutic strategies directed to prevent the activation of this program could be a new approach worth exploring to facilitate the clearance of the pathogen from the airways.
